Literature DB >> 11508793

Pro-atrial natriuretic peptide hormone from right atria is correlated with cardiac depression in septic patients.

B Mazul-Sunko1, N Zarkovic, N Vrkic, R Klinger, M Peric, M Bekavac-Beslin, M Novkoski, A Krizmanic, A Gvozdenovic, E Topic.   

Abstract

N-terminal pro-atrial natriuretic peptide [proANP(1-98)] has been extensively investigated in patients with chronic heart failure and ishemic heart disease. It is found to be a better marker of cardiac dysfunction than atrial natriuretic peptide (ANP). The possible involvement of proANP(1-98) in cardiac depression caused by sepsis has not been studied yet. Therefore, we analyzed atrial plasma concentration of proANP(1-98) in 17 septic patients with hemodynamic variables measured or calculated using pulmonary artery catheter. The results of altogether 96 measurements show a significant negative correlation of proANP(1-98) and cardiac index (p<0.024), oxygen delivery (p<0.03) and oxygen consumption (p<0.03). There is also a positive correlation with pulmonary vascular resistance (p<0.03). ProANP(1-98) is significantly higher in patients who developed acute respiratory distress syndrome (ARDS) (p<0.001). This study implies that proANP(1-98) is a possible novel hormone marker of cardiac depression caused by sepsis that could be used for prediction of ARDS.

Entities:  

Mesh:

Year:  2001        PMID: 11508793     DOI: 10.1007/BF03343878

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  12 in total

1.  Brain natriuretic peptide as bridge to therapy for heart failure.

Authors:  D L Dries; L W Stevenson
Journal:  Lancet       Date:  2000-04-01       Impact factor: 79.321

Review 2.  Natriuretic peptides.

Authors:  E R Levin; D G Gardner; W K Samson
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

3.  A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.

Authors:  A J de Bold; H B Borenstein; A T Veress; H Sonnenberg
Journal:  Life Sci       Date:  1981-01-05       Impact factor: 5.037

4.  Atrial natriuretic peptide release is more dependent on atrial filling volume than on filling pressure in chronic congestive heart failure.

Authors:  S Globits; H Frank; B Pacher; M Huelsmann; E Ogris; R Pacher
Journal:  Am Heart J       Date:  1998-04       Impact factor: 4.749

5.  alpha-atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock.

Authors:  K J Hartemink; A B Groeneveld; M C de Groot; R J Strack van Schijndel; G van Kamp; L G Thijs
Journal:  Crit Care Med       Date:  2001-01       Impact factor: 7.598

6.  Plasma alpha-atrial natriuretic peptide concentrations in acute respiratory failure associated with sepsis: preliminary study.

Authors:  C Mitaka; T Nagura; N Sakanishi; Y Tsunoda; H Toyooka
Journal:  Crit Care Med       Date:  1990-11       Impact factor: 7.598

7.  Plasma N-terminal atrial natriuretic peptide in acute myocardial infarction.

Authors:  R V Kettunen; J Leppäluoto; A Jounela; O Vuolteenaho
Journal:  Am Heart J       Date:  1994-06       Impact factor: 4.749

8.  Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and/or kaliuresis in humans.

Authors:  D L Vesely; M A Douglass; J R Dietz; W R Gower; M T McCormick; G Rodriguez-Paz; D D Schocken
Journal:  Circulation       Date:  1994-09       Impact factor: 29.690

9.  Circulating beta-atrial natriuretic factor in congestive heart failure in humans.

Authors:  C M Wei; P C Kao; J T Lin; D M Heublein; H V Schaff; J C Burnett
Journal:  Circulation       Date:  1993-09       Impact factor: 29.690

10.  The gene encoding atrial natriuretic peptide and the risk of human stroke.

Authors:  S Rubattu; P Ridker; M J Stampfer; M Volpe; C H Hennekens; K Lindpaintner
Journal:  Circulation       Date:  1999-10-19       Impact factor: 29.690

View more
  6 in total

1.  The prognostic value of atrial and brain natriuretic peptides, troponin I and C-reactive protein in patients with sepsis.

Authors:  Tuba Yucel; Dilek Memiş; Beyhan Karamanlioglu; Necdet Süt; Mahmut Yuksel
Journal:  Exp Clin Cardiol       Date:  2008

2.  Natriuretic peptides: Diagnostic and therapeutic use.

Authors:  Kaushik Pandit; Pradip Mukhopadhyay; Sujoy Ghosh; Subhankar Chowdhury
Journal:  Indian J Endocrinol Metab       Date:  2011-10

3.  Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study.

Authors:  Nils G Morgenthaler; Joachim Struck; Mirjam Christ-Crain; Andreas Bergmann; Beat Müller
Journal:  Crit Care       Date:  2004-12-17       Impact factor: 9.097

Review 4.  Recently published papers: new evidence for old debates, new drugs and some timely reminders.

Authors:  Jonathan Ball; Gareth Williams
Journal:  Crit Care       Date:  2002-09-05       Impact factor: 9.097

Review 5.  Science review: natriuretic peptides in critical illness.

Authors:  Rochus Witthaut
Journal:  Crit Care       Date:  2004-06-17       Impact factor: 9.097

6.  Elevated MR-proANP plasma concentrations are associated with sepsis and predict mortality in critically ill patients.

Authors:  Eray Yagmur; Johanna Hermine Sckaer; Ger H Koek; Ralf Weiskirchen; Christian Trautwein; Alexander Koch; Frank Tacke
Journal:  J Transl Med       Date:  2019-12-12       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.